In breast carcinomas with EGFR over-expression, NF-κB was reportedly activated [17], which was also linked to unfavorable prognosis by promoting tumor metastasis and inhibiting apoptosis [18,20]. The gene discussed is NFKB1; the disease is breast carcinoma.